|
Jan 8
|
CytomX Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
|
|
Jan 7
|
All You Need to Know About CytomX Therapeutics (CTMX) Rating Upgrade to Strong Buy
|
|
Jan 6
|
CytomX Therapeutics Announces 2025 Strategic Pipeline Priorities and Provides Corporate Update
|
|
Jan 3
|
Here's Why Arcutis Stock More Than Doubled in Market Value in One Year
|
|
Jan 3
|
MESO Stock Surges 80% in a Month After FDA Approval of GVHD Drug
|
|
Jan 3
|
CAPR Stock Up on Completion of Rolling Submission of DMD Drug BLA
|
|
Jan 3
|
Neumora Stock Hits Record Low on Depression Drug Study Failure
|
|
Jan 2
|
PGEN Stock Surges More Than 40% in a Week: What's Driving the Rally?
|
|
Jan 2
|
VSTM Up as NDA for Ovarian Cancer Combo Gets FDA's Priority Review Tag
|